Zdrowie i gospodarka · 19/06/2007

Human Cells, Tissues, and Cellular and Tissue-Based Products; Donor Screening and Testing, and Related Labeling

The Food and Drug Administration (FDA) is adopting as a final rule, without change, the provisions of the interim final rule that amended certain regulations regarding the screening and testing of donors of human cells, tissues, and cellular and tissue-based products (HCT[sol]Ps), and related labeling. FDA is taking this action to complete the rulemaking initiated with the interim final rule.